Ironwood Pharmaceuticals Lays Out Ambitious 2026 Outlook
Strong LINZESS growth, rising profitability, and pipeline progress underpin confidence despite pricing changes Ironwood Pharmaceuticals (IRWD) entered 2026 with a ...
Strong LINZESS growth, rising profitability, and pipeline progress underpin confidence despite pricing changes Ironwood Pharmaceuticals (IRWD) entered 2026 with a ...
© 2024 All Rights Reserved: STOXPO.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information
Do you really wish to opt-out?